C Packard
Overview
Explore the profile of C Packard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
594
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arndt P, Huennekens J, Packard C, Tran V, Carey J, Livingston R, et al.
J Chem Phys
. 2020 Nov;
153(18):184310.
PMID: 33187424
We report results of an experimental study of the changes in the alignment of the rotational angular momentum of diatomic molecules during elastic collisions. The experiment involved collisions of diatomic...
2.
Burgess S, Thompson S, Andrews G, Hall A, Whincup P, Morris R, et al.
Stat Med
. 2010 Mar;
29(12):1298-311.
PMID: 20209660
Genetic markers can be used as instrumental variables, in an analogous way to randomization in a clinical trial, to estimate the causal relationship between a phenotype and an outcome variable....
3.
Packard C
J Gen Physiol
. 2009 Oct;
7(3):363-72.
PMID: 19872143
1. The permeability of Paramecium to NH(4)OH is greater when the cells are exposed to light than it is when they are in darkness. 2. This change can be demonstrated...
4.
5.
Batty G, Wang Y, Brouilette S, Shiels P, Packard C, Moore J, et al.
J Epidemiol Community Health
. 2009 May;
63(10):839-41.
PMID: 19468018
Background: It has been hypothesised that socioeconomically deprived people age more rapidly than their more advantaged counterparts and this is biologically manifest in shorter telomeres. However, in the very few...
6.
Danesh J, Erqou S, Walker M, Thompson S, Tipping R, Ford C, et al.
Eur J Epidemiol
. 2007 Sep;
22(12):839-69.
PMID: 17876711
Many long-term prospective studies have reported on associations of cardiovascular diseases with circulating lipid markers and/or inflammatory markers. Studies have not, however, generally been designed to provide reliable estimates under...
7.
Adiels M, Westerbacka J, Soro-Paavonen A, Hakkinen A, Vehkavaara S, Caslake M, et al.
Diabetologia
. 2007 Sep;
50(11):2356-65.
PMID: 17849096
Aims/hypothesis: Overproduction of VLDL(1) seems to be the central pathophysiological feature of the dyslipidaemia associated with type 2 diabetes. We explored the relationship between liver fat and suppression of VLDL(1)...
8.
Geberhiwot T, Alger S, McKiernan P, Packard C, Caslake M, Elias E, et al.
J Inherit Metab Dis
. 2007 Apr;
30(3):406.
PMID: 17407002
With current dietary therapy, life expectancy in glycogen storage disease (GSD) has improved considerably and more children reach adulthood. Notwithstanding intensive dietary therapy, moderate to severe hyperlipidaemia is still observed...
9.
Psaty B, Furberg C, Khaw K, Sandhu M, Oldgren J, Rossi G, et al.
Eur J Cardiovasc Prev Rehabil
. 2007 Feb;
14(1):3-11.
PMID: 17301621
Background: A large number of observational epidemiological studies have reported generally positive associations between circulating mass and activity levels of lipoprotein-associated phospholipase A2 (Lp-PLA2) and the risk of cardiovascular diseases....
10.
Adiels M, Taskinen M, Packard C, Caslake M, Soro-Paavonen A, Westerbacka J, et al.
Diabetologia
. 2006 Feb;
49(4):755-65.
PMID: 16463046
Aims/hypothesis: We determined whether hepatic fat content and plasma adiponectin concentration regulate VLDL(1) production. Methods: A multicompartment model was used to simultaneously determine the kinetic parameters of triglycerides (TGs) and...